Capsida Biotherapeutics

View the org chart displaying its 13 main executives

Most searched biographies at Capsida Biotherapeutics

• Peter Anastasiou, Chief Executive Officer and Director
• Rita Balice-Gordon, Director
• Viviana Gradinaru, Director

Popular executive movements at Capsida Biotherapeutics

• Rob Murphy, who was Vice President, Technical Operations, is promoted to Chief Manufacturing and Quality Officer  (posted on March 13 2024).

Create your alert
to follow the executive moves at Capsida Biotherapeutics.

Capsida Biotherapeutics has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Capsida Biotherapeutics

Social media about Capsida Biotherapeutics

• Capsida Biotherapeutics on Wikipedia, Google News & Yahoo Finance
• Capsida Biotherapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Peter Anastasiou

Call Capsida Biotherapeutics at +1 888...

View the org chart

Register to receive your alert

Report an error